FCAG
WST icon

First Capital Advisors Group’s West Pharmaceutical WST Stock Holding History

First Capital Advisors Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$9.94K Buy
+26
New +$9.29K 0.01% 550
2018
Q2 		– Sell
-32
Closed -$3K – 774
2018
Q1 		$3K Buy
+32
New +$2.99K ﹤0.01% 710

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

First Capital Advisors Group's WST Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in West Pharmaceutical (WST) in Q2 2023: 26 shares worth $9.94K. The stake represents 0.01% of the portfolio and ranks #550 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in WST as recently as Q1 2018.

First Capital Advisors Group first reported a position in WST in Q1 2018 and has held it in 2 quarters since. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • First Capital Advisors Group held 26 shares of West Pharmaceutical worth $9.94K as of Q2 2023.
  • West Pharmaceutical was a new First Capital Advisors Group position in Q2 2023.
  • West Pharmaceutical made up 0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #550 holding.
  • First Capital Advisors Group first reported a position in West Pharmaceutical in Q1 2018 and has held it in 2 quarters since.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.